An Open-label, Single-arm, Multicenter Phase II Study to Evaluate the Efficacy of Amivantamab in Combination With FOLFIRI as a Second-line Treatment in Patients With RAS/BRAF Wild-type Advanced Colorectal Cancer Progressing on Prior Anti-EGFR Based Treatment.
Clinical trial NCT06855849 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06855849
- Sponsor
- Yonsei University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.